Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 22

1.

Low frequency 3D ultra-wide vibration attenuation via elastic metamaterial.

D'Alessandro L, Ardito R, Braghin F, Corigliano A.

Sci Rep. 2019 May 29;9(1):8039. doi: 10.1038/s41598-019-44507-6.

2.

3-D Design and Simulation of a Piezoelectric Micropump.

Farshchi Yazdi SAF, Corigliano A, Ardito R.

Micromachines (Basel). 2019 Apr 18;10(4). pii: E259. doi: 10.3390/mi10040259.

3.

Prognostic and predictive role of elevated lactate dehydrogenase in patients with melanoma treated with immunotherapy and BRAF inhibitors: a systematic review and meta-analysis.

Petrelli F, Ardito R, Merelli B, Lonati V, Cabiddu M, Seghezzi S, Barni S, Ghidini A.

Melanoma Res. 2019 Feb;29(1):1-12. doi: 10.1097/CMR.0000000000000520.

PMID:
30308577
4.

Nine weeks versus 1 year adjuvant trastuzumab in combination with chemotherapy: final results of the phase III randomized Short-HER study‡.

Conte P, Frassoldati A, Bisagni G, Brandes AA, Donadio M, Garrone O, Piacentini F, Cavanna L, Giotta F, Aieta M, Gebbia V, Molino A, Musolino A, Ferro A, Maltoni R, Danese S, Zamagni C, Rimanti A, Cagossi K, Russo A, Pronzato P, Giovanardi F, Moretti G, Lombardo L, Schirone A, Beano A, Amaducci L, Bajardi EA, Vicini R, Balduzzi S, D'Amico R, Guarneri V; Reader study level-I and level-II Groups .

Ann Oncol. 2018 Dec 1;29(12):2328-2333. doi: 10.1093/annonc/mdy414.

PMID:
30219886
5.

Haematological toxicities with immunotherapy in patients with cancer: a systematic review and meta-analysis.

Petrelli F, Ardito R, Borgonovo K, Lonati V, Cabiddu M, Ghilardi M, Barni S.

Eur J Cancer. 2018 Nov;103:7-16. doi: 10.1016/j.ejca.2018.07.129. Epub 2018 Sep 6.

PMID:
30196108
6.

A systematic review and meta-analysis of second-line therapies for treatment of mesothelioma.

Petrelli F, Ardito R, Conti B, Coinu A, Cabiddu M, Ghilardi M, Borgonovo K, Barni S, Ghidini A.

Respir Med. 2018 Aug;141:72-80. doi: 10.1016/j.rmed.2018.06.026. Epub 2018 Jun 30.

PMID:
30053976
7.

Efficacy of ALK inhibitors on NSCLC brain metastases: A systematic review and pooled analysis of 21 studies.

Petrelli F, Lazzari C, Ardito R, Borgonovo K, Bulotta A, Conti B, Cabiddu M, Capitanio JF, Brighenti M, Ghilardi M, Gianni L, Barni S, Gregorc V.

PLoS One. 2018 Jul 27;13(7):e0201425. doi: 10.1371/journal.pone.0201425. eCollection 2018.

8.

3D auxetic single material periodic structure with ultra-wide tunable bandgap.

D'Alessandro L, Zega V, Ardito R, Corigliano A.

Sci Rep. 2018 Feb 2;8(1):2262. doi: 10.1038/s41598-018-19963-1.

9.

Different Toxicity of Cetuximab and Panitumumab in Metastatic Colorectal Cancer Treatment: A Systematic Review and Meta-Analysis.

Petrelli F, Ardito R, Ghidini A, Zaniboni A, Ghidini M, Barni S, Tomasello G.

Oncology. 2018;94(4):191-199. doi: 10.1159/000486338. Epub 2018 Jan 23. Review.

PMID:
29393280
10.

The evolving landscape in advanced penile cancer.

Buonerba C, Di Lorenzo G, Calderoni G, Ferro M, Perri F, Lombardi L, Ardito R, Federico P, Placido S, Aieta M.

Future Sci OA. 2015 Nov 1;1(3):FSO9. doi: 10.4155/fso.15.7. eCollection 2015 Nov. No abstract available.

11.

Long-term survival in small cell lung cancer: a case report and review of the literature.

Tartarone A, Lerose R, Ardito R, Troiani L, Tedesco B, Bozza G, Cangiano R, Aieta M.

Future Oncol. 2014 Mar;10(4):523-8. doi: 10.2217/fon.13.213. Review.

PMID:
24754583
12.

Metabolic syndrome as a peculiar target for management of prostate cancer patients.

Conteduca V, Di Lorenzo G, Bozza G, Ardito R, Aieta M.

Clin Genitourin Cancer. 2013 Sep;11(3):211-20. doi: 10.1016/j.clgc.2013.04.009. Epub 2013 May 21. Review.

PMID:
23701880
13.

Evaluation of molecular prognostic and predictive factors: an important step towards personalised treatment in non small cell lung cancer.

Tartarone A, Lerose R, Gallucci G, Ardito R, Aieta M.

Med Oncol. 2012 Sep;29(3):1599-605. doi: 10.1007/s12032-011-9992-y. Epub 2011 Jun 2. Review.

PMID:
21633836
14.

Simplified FOLFIRI in pre-treated patients with metastatic gastric cancer.

Lorizzo K, Fazio N, Radice D, Boselli S, Ariu L, Zampino MG, Nolè F, Magni E, Ardito R, Minchella I, Rocca A, Di Meglio G, Squadroni M, de Braud F.

Cancer Chemother Pharmacol. 2009 Jul;64(2):301-6. doi: 10.1007/s00280-008-0871-y. Epub 2008 Nov 26.

PMID:
19034450
15.

Prophylactic radiotherapy for glioblastoma in the elderly.

Tartarone A, Ardito R, Romano C.

N Engl J Med. 2007 Jul 12;357(2):196; author reply 196. No abstract available.

PMID:
17626310
16.

Dose-finding study of weekly docetaxel plus estramustine in patients with hormone-refractory metastatic prostate cancer.

Coccaro M, Tartarone A, Romano G, Ardito R, Di Renzo N.

Tumori. 2005 Jul-Aug;91(4):314-6.

PMID:
16277095
17.

Role of parenteral nutrition in cancer patients undergoing high-dose chemotherapy followed by autologous peripheral blood progenitor cell transplantation.

Tartarone A, Wunder J, Romano G, Ardito R, Iodice G, Mazzuoli S, Barone M, Matera R, Di Renzo N.

Tumori. 2005 May-Jun;91(3):237-40. Review.

PMID:
16206647
18.

Cisplatin and weekly docetaxel as first-line therapy in patients with advanced non-small cell lung cancer a phase II study.

Tartarone A, Romano G, Iodice G, Capobianco A, Coccaro M, Bochicchio A, Di Leo P, Ardito R, Di Renzo N.

Tumori. 2005 Mar-Apr;91(2):131-4.

PMID:
15948539
19.

Support ellagic acid therapy in patients with hormone refractory prostate cancer (HRPC) on standard chemotherapy using vinorelbine and estramustine phosphate.

Falsaperla M, Morgia G, Tartarone A, Ardito R, Romano G.

Eur Urol. 2005 Apr;47(4):449-54; discussion 454-5. Epub 2005 Jan 19.

PMID:
15774240
20.

Targeted inhibition of the epidermal growth factor receptor-tyrosine kinase by ZD1839 ('Iressa') induces cell-cycle arrest and inhibits proliferation in prostate cancer cells.

Sgambato A, Camerini A, Faraglia B, Ardito R, Bianchino G, Spada D, Boninsegna A, Valentini V, Cittadini A.

J Cell Physiol. 2004 Oct;201(1):97-105.

PMID:
15281092

Supplemental Content

Loading ...
Support Center